Head-to-head for women
MyDrHank vs yourEra
MyDrHank and yourEra both offer GLP-1 telehealth to women, but they make different trade-offs on PCOS and hormonal suitability, clinical oversight, price and access. Here they are side-by-side on the Luna Fit Score — our women's-health rubric.
MyDrHank
Ranked #47 for women · Grade C
Luna Fit
Best for: Readers treating insulin resistance who want tirzepatide at a price that does not climb with the dose, and who will open the plan selector and pay the month-to-month rate rather than the advertised one.
Visit MyDrHankyourEra
Higher scoreRanked #3 for women · Grade B
Luna Fit
Best for: Women who want transparently priced semaglutide and tirzepatide plus an optional NAD+, microdosing, and coaching-and-labs menu on one account.
Visit yourEraThe verdict for women
yourEra edges out MyDrHank on the Luna Fit Score, 86 to 73 (B vs C). Women who want transparently priced semaglutide and tirzepatide plus an optional NAD+, microdosing, and coaching-and-labs menu on one account. The reasoning behind that number is in our full yourEra review.
MyDrHank is still a genuine option — a flat, all-dose price on both molecules — including the tirzepatide most insulin-resistance readers are actually here for — from a general telehealth shop that publishes its ladder openly but shows you only the twelve-month rung of it. Weigh the six women's-health factors below against your own priorities; our MyDrHank write-up for women goes through each of them, and if neither of these two is the one, what women pick instead of MyDrHank widens the field.
Side-by-side on the six factors
Both providers scored on the same women's-health rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | MyDrHank | yourEra |
|---|---|---|
| Luna Fit Score | 73/100 · C | 86/100 · B |
| Overall rank | #47 | #3 |
| Semaglutide | $259/mo month-to-month (from $178/mo on a 12-month prepay, $2,140 up front) — the site displays only the prepay rate | $199/mo |
| Tirzepatide | $349/mo month-to-month (from $240/mo on a 12-month prepay, $2,883 up front) — the site displays only the prepay rate | $299/mo |
| Coverage | No state list published; its affiliate terms exclude Kansas, Louisiana, Mississippi, New Mexico, North Dakota and West Virginia | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Injection only |
Luna Fit
MyDrHank
Ranked #47 · Grade C
What we like
- Tirzepatide is a first-class option here, not an upsell — the dual GIP/GLP-1 agonist is the one most readers arriving on insulin-resistance questions ask about by name
- The price does not move with the dose: its GLP-1 FAQ states "the price stays the same at every dose — no surprise price increases", so a titration to a higher dose does not re-price the plan
- Prices are published before any intake quiz — the full four-rung ladder for every product, with the up-front total beside each per-month figure, rather than a number you have to qualify for
The caveats
- Every price the site displays is the TWELVE-MONTH PREPAY rate — the renderer takes the cheapest rung of the ladder — so the month-to-month figures ($349 tirzepatide, $259 semaglutide) are shown on no page at all
- Its own footnote advertises a tirzepatide price that exists at no tier: "Plans start at $171/mo for compounded semaglutide and $200/mo for compounded tirzepatide" — $200 appears exactly once in the entire site bundle and no tirzepatide rung costs it; the $171 in the same sentence is the ORAL product's yearly rate, while injectable semaglutide's is $178
- The GLP-1 FAQ calls a prepaid annual rate a plan with "no contract", which is true of the paperwork and misleading about the money
Luna Fit
yourEra
Ranked #3 · Grade B
What we like
- Publicly listed pricing on both molecules — semaglutide from $199/mo and tirzepatide from $299/mo — while many compounders hide price behind a quiz
- Fuller menu beyond GLP-1: NAD+ and microdosing protocols, plus an optional membership adding 1:1 coaching, a nutritionist, and an at-home lab draw
- Markets a 50-state licensed-clinician network, no insurance required, with HSA/FSA accepted
The caveats
- Compounded semaglutide and tirzepatide are not FDA-approved the way brand Wegovy, Ozempic, or Zepbound are, and compounding access can tighten as brand shortages resolve
- Mid-market pricing that sits above the cheapest compounders (roughly $99–$150)
- Injectable only — no oral route and no brand-name lane
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. Pricing, states and verification reflect each provider's public disclosures at last review; the Luna Fit Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Neither MyDrHank nor yourEra is only worth comparing with the other. MyDrHank is also written up against CoreAge Rx, 20 points apart on the Luna Fit Score — see MyDrHank against CoreAge Rx, factor by factor. yourEra is also written up against CoreAge Rx, 7 points apart — see how yourEra and CoreAge Rx compare on the Luna Fit Score.
- MyDrHank vs CoreAge Rx
- MyDrHank vs Enhance MD
- MyDrHank vs Sesame Care
- yourEra vs HealthRX
- yourEra vs MadeMed
- yourEra vs Trimi
Or browse the full comparison hub.